Journal Editors Owe Readers Timely Action On Retractions

It is a truism that we live in a litigious age. More than ever before, it seems, neighbor is inclined to sue neighbor - and at the drop of a hat. As I know all too well, proprietors and managers in business spend inordinate time with lawyers. Frequently, business people must appear in court to deal with what can only be described as nuisance suits. Physicians, too, have been forced into a defensive posture. Many are ordering more diagnostic tests than their patients really need to avoid malpra

Written byEugene Garfield
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

It is a truism that we live in a litigious age. More than ever before, it seems, neighbor is inclined to sue neighbor - and at the drop of a hat. As I know all too well, proprietors and managers in business spend inordinate time with lawyers. Frequently, business people must appear in court to deal with what can only be described as nuisance suits. Physicians, too, have been forced into a defensive posture. Many are ordering more diagnostic tests than their patients really need to avoid malpractice or negligence suits.

Should we be surprised, then, that such fears have seeped into the world of science?

In particular, many journal editors have exhibited a reluctance to print retractions to articles that have appeared in their publications because they fear defamation suits by an author or coauthor. Unfortunately, in several cases, the editor's obligation to correct the scientific record has been ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies